ArticleJournal of managed care & specialty pharmacy2025

Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspective.

Jason Shafrin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.